This analysis reveals the antibacterial activity of fatty acids in coconut oil against S. aureus and MRSA, suggesting processing methods influence effectiveness.
This study investigated the antibacterial activity of fatty acids (FAs) extracted from coconut oil against Staphylococcus aureus and Methicillin-resistant S. aureus (MRSA). The FAs exhibited inhibitory effects at concentrations ≥5%, producing inhibition zones of 4 mm and above. Increasing concentration did not yield a proportional enhancement, indicating a non–dose-dependent effect. MRSA displayed slightly greater susceptibility than S. aureus at equivalent concentrations. Significant differences among concentrations were confirmed (p < 0.01). Although overall activity was comparable between cold-pressed (CCO) and hot-extracted coconut oil (HCO), FAs derived from CCO showed stronger inhibition, with minimum inhibitory concentrations (MICs) of 0.39% for both strains, compared to 0.78% for HCO against S. aureus. The superior efficacy of CCO-derived FAs likely reflects better preservation of medium-chain fatty acids—particularly lauric, capric, and caprylic acids—known for antimicrobial properties. These results highlight the influence of processing methods on the antibacterial efficacy of coconut oil–derived fatty acids.
No takes yet. Share an insight, caveat, or question.
My et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: